PVLA 8-K: SEC filing
Palvella Therapeutics
Filed with the SEC on · accession 0001193125-26-467823
PVLA filed a 8-K (current report) with the SEC on Nov 19, 2026. A report of a major event, filed within four business days: results, deals, leadership changes, bankruptcy and more.
Summary of the filing
Palvella Therapeutics announced the third product candidate from its QTORIN platform, QTORIN Docetaxel, for the treatment of Extramammary Paget's disease, and hosted an investor conference call to present the program.
Key details
✦ Ask GOAX AI about this filing — what it means for PVLA, what changed since its last filings and what to watch next.
Try it free for 7 days🔔 Want to stay updated on new SEC filings for PVLA?
Click hereFrequently asked questions
What did PVLA file with the SEC on Nov 19, 2026?
PVLA filed a 8-K (SEC filing). Palvella Therapeutics announced the third product candidate from its QTORIN platform, QTORIN Docetaxel, for the treatment of Extramammary Paget's disease, and hosted an investor conference call to present the program.
How do I read a 8-K?
A report of a major event, filed within four business days: results, deals, leadership changes, bankruptcy and more. The "Item" number tells you the topic (e.g. 2.02 results, 5.02 executive change, 1.01 new agreement, 1.03 bankruptcy). Exhibits (99.1 press release) usually hold the details.
Why are SEC filings important?
Public companies must tell the SEC about anything that can change their value — results, leadership changes, big deals, new shares, bankruptcy. Filings are the official source, often before the news. A 8-K (current report): A report of a major event, filed within four business days: results, deals, leadership changes, bankruptcy and more.
Other PVLA SEC filings
- SCHEDULE 13G/A · SEC filingNov 16, 2026
- 10-Q · SEC filingNov 5, 2026
- 8-K · SEC filingNov 5, 2026
- 8-K · Fda approvalOct 28, 2026
- SCHEDULE 13G/A · SEC filingOct 28, 2026
- SCHEDULE 13G/A · SEC filingAug 14, 2026
- SCHEDULE 13G/A · SEC filingAug 14, 2026
- SCHEDULE 13G · SEC filingAug 10, 2026
- 8-K · SEC filingAug 4, 2026
- 10-Q · SEC filingAug 4, 2026
Get alerts when PVLA files with the SEC, plus live charts, key levels and news for 13,000+ stocks.
Try SEPT free for 7 days